Why the study?
Does enalapril alter blood glucose, insulin, and C-peptide levels in hypertensive patients with non-insulin-dependent diabetes?
Population
22 hypertensive patients with non-insulin-dependent diabetes
Design
Cohort
Follow-up
13 weeks
Authors
Loading...
Reassures on glycemic neutrality with enalapril in hypertensive T2D; observational data leaves open confirmation in RCTs.
Does enalapril alter blood glucose, insulin, and C-peptide levels in hypertensive patients with non-insulin-dependent diabetes?
Enalapril effectively lowers blood pressure in hypertensive patients with type 2 diabetes without adversely affecting glucose metabolism, insulin, or C-peptide levels.
Moore et al. (1988) studied this question.